Rss Feed

An article by Mississippi State Professor of Anthropology Molly Zuckerman and her graduate student Lydia Bailey has been published in Science, one of the foremost scientific journals in the world.

A new study revealed that certain brain regions are more active in people with obsessive-compulsive disorder (OCD) during cognitively demanding tasks.

Public misunderstanding about medical aid in dying in the United States falls into two distinct categories – misinformation and uncertainty – and each is driven by different forces, according to Rutgers Health researchers.

Why do some people feel chills when listening to music, reading poetry, or viewing a powerful work of art, while others do not? New research by Giacomo Bignardi and his colleagues from Max Planck Institute for Psycholinguistics (MPI) published in PLOS Genetics reveals that part of the answer lies in our genes.

Chronic pain lasts longer for women than men, and new research suggests differences in hormone-regulated immune cells, called monocytes, may help explain why.

For adults with asthma, having fans, air purifiers or other ventilation and exhaust systems - especially in kitchens and bathrooms - is one of the best ways to reduce the risk of flare-ups at home.

A single exposure to a toxic fungicide during pregnancy can increase the risk of disease for 20 subsequent generations - with inherited health problems worsening many generations after exposure.

A new study provides hope that smarter timing of cancer treatments could improve cure rates.

A new study of more than 1,500 boys and men in Canada and the United States suggests that social media may play a meaningful role in shaping intentions to use anabolic-androgenic steroids (AAS), particularly when users are exposed to muscularity-focused content and engage in body comparisons online.

For many people diagnosed with cancer, treatment with immune checkpoint inhibitors (ICIs) has dramatically extended lives.

Adults with intellectual and developmental disabilities, such as autism and Down syndrome, experience substantially higher rates of anxiety and depression than the general population of adults, researchers reported today in JAMA Network Open.

Adolescents who use cannabis could face a significantly higher risk of developing serious psychiatric disorders by young adulthood, according to a large new study published today in JAMA Health Forum.

Tropical cyclones, including hurricanes and tropical storms, are linked to increased rates of drug-related deaths up to three months after the storm passes-particularly in higher-income, White communities and among younger populations.

A researcher with the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases at UT Health San Antonio has received a two-year, $402,500 grant award from the Cure Alzheimer's Fund to study how microglia, the brain's resident immune cells, paradoxically might contribute to the spread of toxic forms of tau protein in the disease.

The protein "neurofilament light chain" (NfL) – studied in humans in the context of neurodegenerative diseases and aging – is also detectable in the blood of numerous animals, and NfL levels increase with age in mice, cats, dogs, and horses.

Acinetobacter baumannii is a bacteria which can become a virulent killer in health-care settings among severely ill patients. The germ has rapidly developed drug resistance to even last-line carbapenem drugs.

A new paper was published in Volume 13 of Oncoscience on February 6, 2026, titled "Gastrointestinal toxicity of targeted cancer therapies in the United States: Clinicopathologic patterns, FDA safety frameworks, and implications for national patient protection."

For the first time, researchers show that tirzepatide - the active ingredient in the diabetes and weight-loss drug Mounjaro - reduces alcohol intake as well as relapse-like behaviors in rats and mice.

Current models of mortality risk after heart failure (HF) rely primarily on cardiac-specific clinical variables and may underestimate risk in elderly East Asian patients.

An increase in the number of percutaneous coronary interventions does not appear to have resulted in reduced mortality rates, according to results presented today at the EAPCI Summit 2026.